Thermo Fisher Scientific (TMO) PT Raised to $730 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts TMO Hot Sheet
Price: $694.02 +0.97%
Rating Summary:
35 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 17 | New: 31
Rating Summary:
35 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 17 | New: 31
Join SI Premium – FREE
Morgan Stanley analyst Kallum Titchmarsh raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $730.00 (from $650.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Thermo Fisher Scientific (TMO) PT Raised to $785 at Jefferies
- Thermo Fisher Scientific Reports Third Quarter 2026 Results
- Eternal Ltd (ETERNAL:IN) PT Raised to INR417 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
